Advertisement
U.S. markets closed

Balance Labs, Inc. (BLNC)

Other OTC - Other OTC Delayed Price. Currency in USD
0.25000.0000 (0.00%)
At close: 10:17AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2500
Open0.2500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2500 - 0.2500
52 Week Range0.2350 - 0.2500
Volume2,000
Avg. Volume31
Market Cap5.418M
Beta (5Y Monthly)-0.21
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateFeb 26, 2024 - Mar 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BLNC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BALANCE LABS INC
    CADE: Raising target price to $22.00CADENCE BANK has an Investment Rating of SELL; a target price of $22.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.